Regeneron Pharmaceuticals
REGN
#286
Rank
NZ$132.47 B
Marketcap
NZ$1,250
Share price
4.86%
Change (1 day)
-6.44%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): NZ$8.82 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$14.24 Billion. In 2024 the company made an earning of NZ$8.22 Billion, an increase over its 2023 earnings that were of NZ$7.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$8.82 B7.33%
2024 NZ$8.22 B13.83%
2023 NZ$7.22 B-13.57%
2022 NZ$8.36 B-47.9%
2021 NZ$16.05 B144.75%
2020 NZ$6.55 B56.86%
2019 NZ$4.18 B-4.87%
2018 NZ$4.39 B22.86%
2017 NZ$3.57 B56.3%
2016 NZ$2.28 B8.55%
2015 NZ$2.10 B54.53%
2014 NZ$1.36 B11.14%
2013 NZ$1.22 B72.13%
2012 NZ$0.71 B-285.93%
2011 -NZ$0.39 Billion121.73%
2010 -NZ$0.18 Billion37.18%
2009 -NZ$0.13 Billion-14.6%
2008 -NZ$0.15 Billion-25.02%
2007 -NZ$0.2 Billion6.32%
2006 -NZ$0.19 Billion-186.52%
2005 NZ$0.21 B2103.7%
2004 NZ$9.71 M-105.66%
2003 -NZ$0.18 Billion-18.18%
2002 -NZ$0.21 Billion42.33%
2001 -NZ$0.15 Billion129.35%
2000 -NZ$64.31 Million51.87%
1999 -NZ$42.35 Million92.19%
1998 -NZ$22.04 Million66.23%
1997 -NZ$13.26 Million-55.49%
1996 -NZ$29.78 Million103.53%
1995 -NZ$14.64 Million-70.89%
1994 -NZ$50.26 Million-26.08%
1993 -NZ$67.99 Million114.67%
1992 -NZ$31.68 Million196.77%
1991 -NZ$10.68 Million87.88%
1990 -NZ$5.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.18 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.27 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.75 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.26 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$15.66 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France